<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38465660</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China.</ArticleTitle><Pagination><StartPage>2319967</StartPage><MedlinePgn>2319967</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2319967</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2024.2319967</ELocationID><Abstract><AbstractText>Congenital heart disease (CHD) represents a significant population warranting particular attention concerning vaccination coverage. To comprehend the vaccination status of CHD within Yinzhou District, Ningbo City, China, and to facilitate the formulation of preventive, control, and immunization strategies against vaccine-preventable diseases in children with congenital heart conditions. Using the China Yinzhou Electronic Health Record Study (CHERRY) database, we analyzed the vaccination coverage of children with CHD born between January 1, 2016 and September 20, 2021, and analyzed the influencing factors associated with the level of vaccination coverage. This study involved 762 children diagnosed with CHD at the age of 12 months, revealing that 86.74% of these children had received at least one dose of the National Immunization Program (NIP) vaccines. The coverage for non-NIP vaccines, such as the rotavirus vaccine, influenza vaccine, Influenza Haemophilus influenzae Type b (Hib) Conjugate Vaccine, 13-valent pneumococcal conjugate vaccine (PCV13), and inactivated enterovirus type 71 vaccine (EV71), stood at 27.30%, 7.74%, 63.25%, 33.76%, and 34.51%, respectively. The completion coverage for the entire vaccination schedule were 27.30%, 5.51%, 55.77%, 34.25%, and 25.59%, respectively. There was a statistically significant correlation between vaccination coverage in classification of diagnostic medical institutions and the types of diagnosed diseases. Compared to their typically developing counterparts, 12-month-old children afflicted with CHD exhibit a slightly diminished vaccination coverage, alongside a discernible inclination toward delayed vaccination. Notably, the determination to undergo vaccinations seems predominantly influenced by the classification of diagnostic medical institutions. In practical terms, proactive measures involving early diagnosis, comprehensive health assessments, and timely interventions ought to be implemented to enhance vaccination rates while prioritizing safety.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ziliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Yueqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wenzan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Tianfei</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ping</LastName><ForeName>Jianming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical School, Department of Preventive Medicine, Ningbo University, Ningbo, Zhejiang, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yexiang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0005-7258-138X</Identifier><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018074">Vaccines, Conjugate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018074" MajorTopicYN="N">Vaccines, Conjugate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Congenital heart disease (CHD)</Keyword><Keyword MajorTopicYN="N">NIP vaccines</Keyword><Keyword MajorTopicYN="N">non-NIP vaccines</Keyword><Keyword MajorTopicYN="N">vaccination coverage</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>7</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38465660</ArticleId><ArticleId IdType="pmc">PMC10936686</ArticleId><ArticleId IdType="doi">10.1080/21645515.2024.2319967</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC . What are congenital heart Defects?[EB/OL]; 2023. 
Feb
2 [accessed 2023 Mar 23]. https://www.cdc.gov/ncbddd/heartdefects/facts.html.</Citation></Reference><Reference><Citation>Wu W, He J, Shao X.. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017. Medicine (Baltimore). 2020;99(23):e20593. doi:10.1097/MD.0000000000020593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000020593</ArticleId><ArticleId IdType="pmc">PMC7306355</ArticleId><ArticleId IdType="pubmed">32502030</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel HY, Ratheesh R, Anum, Thota AK, Rachapudi SV, John J, Koppana V, Hassan KM, Desai HD. Abstract 18555: global burden of congenital heart disease and its trend from 1990-2019 in 38 OECD countries: a benchmarking analysis for the global burden of disease study. Circulation. 2023;148(Suppl_1):18555. doi:10.1161/circ.148.suppl_1.18555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.148.suppl_1.18555</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, Xu W, Li J, Huang Z, Shu Q. Trends in the disease burden of congenital heart disease in China over the past three decades. J Zhejiang Univ. 2022;51(3):267–11. doi:10.3724/zdxbyxb-2022-0072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/zdxbyxb-2022-0072</ArticleId><ArticleId IdType="pmc">PMC10251186</ArticleId><ArticleId IdType="pubmed">36207836</ArticleId></ArticleIdList></Reference><Reference><Citation>Shengshou H, Runlin G, Lisheng L, Manlu Z, Wen W, Yongjun W, Zhaosu W, Huijun L, Dongfeng G, Yuejin Y, Zhe Z, Weiwei C. Summary of the 2018 report on cardiovascular diseases in China. Chinese Circ J. 2019;34(3):209–220.</Citation></Reference><Reference><Citation>Zhao L, Chen L, Yang T, Wang T, Zhang S, Chen L, Ye Z, Luo L, Qin J. Birth prevalence of congenital heart disease in China, 1980–2019: a systematic review and meta-analysis of 617 studies. Eur J Epidemiol. 2020;35(7):631–642. doi:10.1007/s10654-020-00653-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00653-0</ArticleId><ArticleId IdType="pmc">PMC7387380</ArticleId><ArticleId IdType="pubmed">32519018</ArticleId></ArticleIdList></Reference><Reference><Citation>Weize X, Jing Jing Y, Feixia P, Yunxia Z, Jiong Y, Hongliang L, Linghua T, Lanqiu L, Yejun J, Min X, Jingli G, Jing L, Jun L, Junqiu X, Qiang S. Epidemiological survey of neonatal congenital heart defect in Zhejiang Province in 2019. 2020 Zhejiang Provincial Medical Association Pediatric Surgery Academic Conference, Zhejiang Provincial Medical Association Pediatric Surgeons Academic Conference, and Zhejiang Anti-Cancer Association Pediatric Oncology Professional Committee Academic Conference Proceedings; 2020; Jiaxing, Zhejiang Province, China. p. 2.</Citation></Reference><Reference><Citation>Zhao Q-M, Ma X-J, Ge X-L, Liu F, Yan W-L, Wu L, Ye M, Liang X-C, Zhang J, Gao Y, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet. 2014;13(1):747–754. doi:10.1016/S0140-6736(14)60198-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60198-7</ArticleId><ArticleId IdType="pubmed">24768155</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Ji C, Zeng Y, Yao D, Wang X, Shao J. Reasons of the delayed vaccination, recommendations and safety of vaccination in children with congenital heart disease in Zhejiang, China. Hum Vaccin Immunother. 2021;17(7):2065–2071. doi:10.1080/21645515.2021.1872343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1872343</ArticleId><ArticleId IdType="pmc">PMC8189144</ArticleId><ArticleId IdType="pubmed">33577372</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Medical Association P C G, Cardiovascular Subgroup, Chinese Medical Doctor Association P P B, Expert Committee on Congenital Heart Disease, Pediatrics E C O C J O . Expert consensus on diagnosis and perinatal management of congenital heart disease in fetuses. Chin J Pediatrics. 2015;10:728–733.</Citation></Reference><Reference><Citation>Woodward CS. Keeping children with congenital heart disease healthy. J Pediatr Health Care. 2011;25(6):373–378. doi:10.1016/j.pedhc.2011.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedhc.2011.03.007</ArticleId><ArticleId IdType="pubmed">22018428</ArticleId></ArticleIdList></Reference><Reference><Citation>Walmsley D, Walmsley D. Routine pediatric immunization, special cases in pediatrics: prematurity, chronic disease, congenital heart disease: recent advancements/changes in pediatric vaccines. Prim Care. 2011;38(4):595–609, vii. doi:10.1016/j.pop.2011.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pop.2011.07.002</ArticleId><ArticleId IdType="pubmed">22094135</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou XY, Yao M, Qi JG, Qi Z-N, Liang W-L. Vaccination in children with congenital heart disease: an observational study in a Beijing hospital. Pediatr Res. 2022;93:2061–2066. doi:10.1038/s41390-022-02344-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02344-w</ArticleId><ArticleId IdType="pmc">PMC10313510</ArticleId><ArticleId IdType="pubmed">36307525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Tang X, Shen P, Zhang D, Wu J, Zhang J, Lu P, Si Y, Gao P. Using big data to improve cardiovascular care and outcomes in China: a protocol for the Chinese electronic health records research in Yinzhou (CHERRY) study. BMJ Open. 2018;8(2):e019698. doi:10.1136/bmjopen-2017-019698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-019698</ArticleId><ArticleId IdType="pmc">PMC5829949</ArticleId><ArticleId IdType="pubmed">29440217</ArticleId></ArticleIdList></Reference><Reference><Citation>China N H C O T P S R O . National immunization program for children immunization procedures and instructions (2016 Edition)[EB/OL]; 2016. 
Dec
6 [accessed 2023 Mar 24]. http://www.nhc.gov.cn/jkj/s3581/201701/a91fa2f3f9264cc186e1dee4b1f24084.shtml.</Citation></Reference><Reference><Citation>Zhang L, Cao L, Li Y, Hu YX, Tang L, Li KL, Yin ZD, An ZJ. Analysis of the vaccination status of enterovirus type 71 inactivated vaccine in China from 2017 to 2021. Chin J Epidemiol. 2023;44(4):561–567.</Citation><ArticleIdList><ArticleId IdType="pubmed">37147826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Chen Y. Evaluating childhood vaccination coverage of NIP vaccines: coverage survey versus Zhejiang provincial immunization information system. Int J Environ Res Public Health. 2017;14(7):758. doi:10.3390/ijerph14070758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph14070758</ArticleId><ArticleId IdType="pmc">PMC5551196</ArticleId><ArticleId IdType="pubmed">28696387</ArticleId></ArticleIdList></Reference><Reference><Citation>Qianqian H, Qian Z, Yuanqiu L, Hui Z, Qianqian L, Lin T, Xiaoqi W, Hong Y, Ning W, Zundong Y, Fuzhen W. Varicella vaccine coverage levels among 1–14–year-old children in China in 2020: a crosssectional survey. Chin J Vaccines Immun. 2022;28(2):169–173+178.</Citation></Reference><Reference><Citation>China T S C O T P S R O . “13th five-year plan” for health and hygiene[EB/OL]; 2017. 
Jan
10 [accessed 2023 Mar 23]. http://www.gov.cn/zhengce/content/2017-01/10/content_5158488.htm.</Citation></Reference><Reference><Citation>Jiakai Y, Lei C, Jiakai Y, Lei C, Wensheng Y, Lingsheng C, Yifan S, Jian C. Surveillance for routine vaccination coverage with national immunization program vaccines among age-eligible children in China, 2016 - 2019. Chin J Vaccines Immun. 2022;28(1):94–100.</Citation></Reference><Reference><Citation>Jiakai Y, Lei C, Wenzhou Y, Yifan S, Zundong Y. Reported routine immunization coverage with National Immunization Program vaccines in China, 2020-2021. Chinese J Vaccines Immun. 2022;28(5):576–580.</Citation></Reference><Reference><Citation>Sanatani G, Franciosi S, Bone JN, Dechert B, Harris KC, Sadarangani M. A survey of immunization practices in patients with congenital heart disease. CJC Pediatr Congenital Heart Dis. 2022;1(2):74–79. doi:10.1016/j.cjcpc.2021.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjcpc.2021.12.003</ArticleId><ArticleId IdType="pmc">PMC10642143</ArticleId><ArticleId IdType="pubmed">37969240</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Immunization coverage[EB/OL]; 2022. 
Jul
14 [accessed 2023 Apr 12]. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage.</Citation></Reference><Reference><Citation>Hu Y, Chen Y, Liang H, Wang Y. Routine vaccination coverage of children aged 1-7 years in Zhejiang province, China. Hum Vaccin Immunother. 2018;14(12):2876–2883. doi:10.1080/21645515.2018.1504523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1504523</ArticleId><ArticleId IdType="pmc">PMC6343626</ArticleId><ArticleId IdType="pubmed">30047821</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbeláez MP, Nelson KE, Muñoz A. BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection. Int J Epidemiol. 2000;29(6):1085–1091. doi:10.1093/ije/29.6.1085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/29.6.1085</ArticleId><ArticleId IdType="pubmed">11101552</ArticleId></ArticleIdList></Reference><Reference><Citation>Verreck FAW, Tchilian EZ, Vervenne RAW, Sombroek CC, Kondova I, Eissen OA, Sommandas V, van der Werff NM, Verschoor E, Braskamp G, et al. Variable BCG efficacy in rhesus populations: pulmonary BCG provides protection where standard intra-dermal vaccination fails. Tuberculosis. 2017;104:46–57. doi:10.1016/j.tube.2017.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tube.2017.02.003</ArticleId><ArticleId IdType="pubmed">28454649</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Tran V, Leung AS, Alexander DC, Zhu B. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin. 2009;5(2):70–78. doi:10.4161/hv.5.2.7210.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.5.2.7210</ArticleId><ArticleId IdType="pubmed">19164935</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie C, Zhiyuan H, Dahai Y, Qiong W, Hai F, Qingyue M. 0-3 years old children category B vaccine self-paid vaccine vaccination associated factor. Chinese J Public Health. 2014;30(5): 579–582.</Citation></Reference><Reference><Citation>Hill HA, Chen M, Elam-Evans LD, Yankey D, Singleton JA. Vaccination coverage by age 24 months among children born during 2018–2019 — national immunization survey–child, United States, 2019–2021. MMWR Morb Mortal Wkly Rep. 2023;72(2):33–38. doi:10.15585/mmwr.mm7202a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7202a3</ArticleId><ArticleId IdType="pmc">PMC9869730</ArticleId><ArticleId IdType="pubmed">36634013</ArticleId></ArticleIdList></Reference><Reference><Citation>Morikawa Y, Morino S, Ito K, Furuichi M, Miyokawa S, Shoji T, Horikoshi Y. Trends in varicella and mumps vaccination rates in children under 3 years of age in a tertiary children’s hospital in Japan. Pediatr Int. 2019;61(9):882–888. doi:10.1111/ped.13916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.13916</ArticleId><ArticleId IdType="pubmed">31211889</ArticleId></ArticleIdList></Reference><Reference><Citation>Peck M, Gacic-Dobo M, Diallo MS, Nedelec Y, Sodha SS, Wallace AS. Global routine vaccination coverage, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(42):937–942. doi:10.15585/mmwr.mm6842a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6842a1</ArticleId><ArticleId IdType="pmc">PMC6812836</ArticleId><ArticleId IdType="pubmed">31647786</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun F, Taihao C, Lifang D, Ning T, Wen D, Xingui Y, Shiguang L. Bivariate spatial autocorrelation analysis of influenza vaccine coverage among children aged 6 months to 5 years during the 2020 – 2021 influenza season and socio-economic indicators in Guizhou province. Chinese J Vaccines Immun. 2022;28(2):199–203.</Citation></Reference><Reference><Citation>Wenmin L, Gang Y, Yumei K, Qiong W. Meta-analysis of Haemophilus influenzae type b (Hib) vaccine coverage among children in China. Chinese J Health Stat. 2017;34(1):69–73.</Citation></Reference><Reference><Citation>Lizhi L. Evaluation of the cost-effectiveness and effects of 13-valent pneumococcal conjugate vaccine for children under 2 years old in Ningbo City. Ningbo University; 2022. doi:10.27256/d.cnki.gnbou.2020.000246.</Citation><ArticleIdList><ArticleId IdType="doi">10.27256/d.cnki.gnbou.2020.000246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenchang W, Huaqing W. Status and influencing factors of vaccination with non-expanded program on immunization vaccines in China. Chin J Vaccines Immun. 2020;26:93–97.</Citation></Reference><Reference><Citation>中国疾病预防控制中心新冠病毒疫苗技术工作组 . 疫情暴发现场新冠病毒疫苗流行病学保护效果评价技术指南(试行). Chin J Vaccines Immun. 2022;28(2):257–262.</Citation></Reference><Reference><Citation>China N H C O T P S R O . Notification of the national health commission on the issuance of the national immunization program vaccine child immunization procedure and instructions (2021 edition)[EB/OL]; 2021. 
Feb
23 [accessed 2023 Apr 9]. http://www.nhc.gov.cn/cms-search/downFiles/7559f978e6be4ec585a9a1fe0d9224f6.pdf.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>